Novanta Inc
$ 160.53
-1.16%
12 Jun - close price
- Market Cap 5,717,004,000 USD
- Current Price $ 160.53
- High / Low $ 166.39 / 156.24
- Stock P/E 114.66
- Book Value 36.81
- EPS 1.40
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.05 %
- 52 Week High 171.85
- 52 Week Low 98.27
About
Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.
Analyst Target Price
$175.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-11 | 2026-02-23 | 2025-11-03 | 2025-08-05 | 2025-05-06 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-28 | 2023-11-07 | 2023-08-08 |
| Reported EPS | 0.81 | 0.91 | 0.87 | 0.76 | 0.74 | 0.76 | 0.85 | 0.73 | 0.74 | 0.63 | 0.85 | 0.8 |
| Estimated EPS | 0.78 | 0.88 | 0.82 | 0.73 | 0.67 | 0.7133 | 0.85 | 0.69 | 0.58 | 0.63 | 0.74 | 0.73 |
| Surprise | 0.03 | 0.03 | 0.05 | 0.03 | 0.07 | 0.0467 | 0 | 0.04 | 0.16 | 0 | 0.11 | 0.07 |
| Surprise Percentage | 3.8462% | 3.4091% | 6.0976% | 4.1096% | 10.4478% | 6.547% | 0% | 5.7971% | 27.5862% | 0% | 14.8649% | 9.589% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.82 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NOVT
2026-06-11 19:12:24
Novanta has announced a private placement of 2,142,857 common shares at $140 per share, aiming to raise $300 million. This move is expected to slightly dilute existing shareholders and is part of the company's strategy to strengthen its balance sheet and maintain funding flexibility through private capital markets. While analysts have issued a Buy rating with a $180 price target, TipRanks' AI Analyst Spark rates NOVT as Neutral due to high valuation and technically extended conditions, despite a strengthened balance sheet and positive earnings momentum.
2026-06-11 02:10:10
Novanta announced its acquisition of Riverpoint Medical for $1.45 billion, a move financed in part by a $300 million private placement. This strategic acquisition is set to expand Novanta's market presence and product offerings. The deal highlights significant M&A activity in the medical technology sector.
2026-06-10 23:10:11
Novanta (NOVT) has announced a private placement of 2,142,857 common shares to institutional investors at $140 per share, raising approximately $300 million in gross proceeds. This deal, expected to close around June 11, 2026, will modestly dilute existing holders, increasing the total share count to roughly 42.5 million. Analysts currently rate NOVT as a "Buy" with a $180 price target, while TipRanks' AI Analyst, Spark, assigns a "Neutral" score due to high valuation and elevated technical conditions despite a strengthened balance sheet.
2026-06-10 08:09:08
This article provides a list of recent news and analysis for Novanta Inc. (NASDAQ:NOVT), including its stock performance and various company announcements. Key updates include passing a quality screen, beating Q1 estimates, announcing a $300 million private placement, and acquiring Riverpoint Medical. The news also highlights Novanta's upcoming presentations at healthcare and technology conferences.
2026-06-09 20:40:29
Novanta Inc. has announced a private placement of 2,142,857 common shares to institutional and accredited investors at $140.00 per share, aiming to raise approximately $300 million. The closing is expected around June 11, 2026, subject to customary conditions. The company has also entered into a Registration Rights Agreement to register the resale of these shares, which were sold in an unregistered transaction relying on Section 4(a)(2) of the Securities Act.
2026-06-09 18:40:29
Boston-based Novanta is set to acquire Riverpoint Medical, a Portland medical device maker, for $1.2 billion. The acquisition involves all outstanding equity interests of Riverpoint's parent company, Arlington Capital Partners.
